Current Neuropharmacology

N1-methylnicotinamide Mediates Multi-Target Cognitive Deficit Relief via AMPK-Lysosome Axis Regulation

Experiments in animalsInterventions

The paper

The Third Xiangya Hospital; Central South University

Current Neuropharmacology, 30 Sep 2026

doi.org/10.2174/011570159x482182260914104640PubMed 42852773